An update on the neurochemistry of Alzheimer disease.
D000110:Acetylcholinesterase / Q000378:metabolism; D000544:Alzheimer Disease / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D001115:Arecoline / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism*; D002794:Choline / Q000627:therapeutic use; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D002799:Cholinergic Fibers; D003704:Dementia / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D018377:Neurotransmitter Agents / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010455:Peptides / Q000378:metabolism; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D018377:Neurotransmitter Agents; D010455:Peptides; D010713:Phosphatidylcholines; D012701:Serotonin; D001115:Arecoline; D005680:gamma-Aminobutyric Acid; D010830:Physostigmine; D002795:Choline O-Acetyltransferase; D000110:Acetylcholinesterase; D002794:Choline; D004298:Dopamine; D009638:Norepinephrine